Dose Dependent Hepatic and Endothelial Changes in Rats Treated with Dexamethasone

Area of Science:

• Pharmacology and Toxicology
• Pathology
• Animal Models

Background:

• Dexamethasone is a potent corticosteroid with known systemic effects.
• Understanding its impact on specific organs like the liver and endothelium is crucial for safe therapeutic use.
• Identifying dose-dependent effects aids in establishing safety profiles and potential adverse outcomes.

Purpose of the Study:

• To investigate the histopathological effects of varying dexamethasone doses on the liver and aortic endothelium in Wistar rats.
• To determine the minimum effective dose of dexamethasone that induces observable pathological changes in these tissues.
• To establish an animal model for screening potential treatments for insulin resistance.

Main Methods:

• Albino Wistar rats were administered daily intraperitoneal injections of dexamethasone at doses ranging from 0.5 to 16 mg/kg for six days.
• A control group received normal saline.
• Liver and aorta tissues were harvested and examined for histopathological alterations under microscopy.

Main Results:

• Dexamethasone at high doses (4, 8, and 16 mg/kg) significantly induced hepatic steatosis (fatty changes in the liver).
• The same high doses also resulted in endothelial thickening of the aorta, indicative of arteriosclerosis.
• Low doses of dexamethasone (0.5, 1, and 2 mg/kg) did not produce significant pathological changes.

Conclusions:

• Acute administration of high-dose dexamethasone (4-16 mg/kg) for six days causes hepatic steatosis and mild to moderate arteriosclerosis in Wistar rats.
• These dexamethasone-induced changes are potentially linked to the development of insulin resistance.
• The study proposes this rat model as a valuable tool for evaluating therapeutic agents targeting insulin resistance.